211 related articles for article (PubMed ID: 26137585)
1. MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation.
Chen TT; Filvaroff E; Peng J; Marsters S; Jubb A; Koeppen H; Merchant M; Ashkenazi A
EBioMedicine; 2015 May; 2(5):406-20. PubMed ID: 26137585
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
3. Targeting the IRE1α/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization.
Liu L; Qi X; Chen Z; Shaw L; Cai J; Smith LH; Grant MB; Boulton ME
Am J Pathol; 2013 Apr; 182(4):1412-24. PubMed ID: 23395094
[TBL] [Abstract][Full Text] [Related]
4. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival.
Chabot C; Spring K; Gratton JP; Elchebly M; Royal I
Mol Cell Biol; 2009 Jan; 29(1):241-53. PubMed ID: 18936167
[TBL] [Abstract][Full Text] [Related]
5. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
6. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
7. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
Fan S; Ma YX; Gao M; Yuan RQ; Meng Q; Goldberg ID; Rosen EM
Mol Cell Biol; 2001 Aug; 21(15):4968-84. PubMed ID: 11438654
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium.
Dellinger MT; Brekken RA
PLoS One; 2011; 6(12):e28947. PubMed ID: 22174934
[TBL] [Abstract][Full Text] [Related]
9. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
[TBL] [Abstract][Full Text] [Related]
10. Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
Takeuchi S; Wang W; Li Q; Yamada T; Kita K; Donev IS; Nakamura T; Matsumoto K; Shimizu E; Nishioka Y; Sone S; Nakagawa T; Uenaka T; Yano S
Am J Pathol; 2012 Sep; 181(3):1034-43. PubMed ID: 22789825
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invasion through induction of vascular endothelial growth factor A.
Jamison S; Lin Y; Lin W
PLoS One; 2015; 10(3):e0120252. PubMed ID: 25794107
[TBL] [Abstract][Full Text] [Related]
12. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.
Wang G; Sun M; Jiang Y; Zhang T; Sun W; Wang H; Yin F; Wang Z; Sang W; Xu J; Mao M; Zuo D; Zhou Z; Wang C; Fu Z; Wang Z; Duan Z; Hua Y; Cai Z
Int J Cancer; 2019 Aug; 145(4):979-993. PubMed ID: 30719715
[TBL] [Abstract][Full Text] [Related]
13. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
15. Melittin protein inhibits the proliferation of MG63 cells by activating inositol-requiring protein-1α and X-box binding protein 1-mediated apoptosis.
Fan Q; Hu Y; Pang H; Sun J; Wang Z; Li J
Mol Med Rep; 2014 Apr; 9(4):1365-70. PubMed ID: 24535635
[TBL] [Abstract][Full Text] [Related]
16. Endoplasmic reticulum quality control in cancer: Friend or foe.
Kim H; Bhattacharya A; Qi L
Semin Cancer Biol; 2015 Aug; 33():25-33. PubMed ID: 25794824
[TBL] [Abstract][Full Text] [Related]
17. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
18. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation.
Yamaoka-Tojo M; Ushio-Fukai M; Hilenski L; Dikalov SI; Chen YE; Tojo T; Fukai T; Fujimoto M; Patrushev NA; Wang N; Kontos CD; Bloom GS; Alexander RW
Circ Res; 2004 Aug; 95(3):276-83. PubMed ID: 15217908
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
20. The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma.
Zhang Y; Gao X; Zhu Y; Kadel D; Sun H; Chen J; Luo Q; Sun H; Yang L; Yang J; Sheng Y; Zheng Y; Zhu K; Dong Q; Qin L
J Exp Clin Cancer Res; 2018 Apr; 37(1):93. PubMed ID: 29712569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
